162 related articles for article (PubMed ID: 35419562)
21. RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue.
Vallarola A; Sironi F; Tortarolo M; Gatto N; De Gioia R; Pasetto L; De Paola M; Mariani A; Ghosh S; Watson R; Kalmes A; Bonetto V; Bendotti C
J Neuroinflammation; 2018 Mar; 15(1):65. PubMed ID: 29495962
[TBL] [Abstract][Full Text] [Related]
22. Silencing strategies for therapy of SOD1-mediated ALS.
van Zundert B; Brown RH
Neurosci Lett; 2017 Jan; 636():32-39. PubMed ID: 27507699
[TBL] [Abstract][Full Text] [Related]
23. Intraspinal cell transplantation for targeting cervical ventral horn in amyotrophic lateral sclerosis and traumatic spinal cord injury.
Lepore AC
J Vis Exp; 2011 Sep; (55):. PubMed ID: 21946609
[TBL] [Abstract][Full Text] [Related]
24. Protein network analysis to prioritize key genes in amyotrophic lateral sclerosis.
Kumar R; Haider S
IBRO Neurosci Rep; 2022 Jun; 12():25-44. PubMed ID: 34918006
[TBL] [Abstract][Full Text] [Related]
25. Adeno-associated virus-delivered artificial microRNA extends survival and delays paralysis in an amyotrophic lateral sclerosis mouse model.
Stoica L; Todeasa SH; Cabrera GT; Salameh JS; ElMallah MK; Mueller C; Brown RH; Sena-Esteves M
Ann Neurol; 2016 Apr; 79(4):687-700. PubMed ID: 26891182
[TBL] [Abstract][Full Text] [Related]
26. Histaminergic transmission slows progression of amyotrophic lateral sclerosis.
Apolloni S; Amadio S; Fabbrizio P; Morello G; Spampinato AG; Latagliata EC; Salvatori I; Proietti D; Ferri A; Madaro L; Puglisi-Allegra S; Cavallaro S; Volonté C
J Cachexia Sarcopenia Muscle; 2019 Aug; 10(4):872-893. PubMed ID: 31020811
[TBL] [Abstract][Full Text] [Related]
27. Disease Mechanisms in ALS: Misfolded SOD1 Transferred Through Exosome-Dependent and Exosome-Independent Pathways.
Silverman JM; Fernando SM; Grad LI; Hill AF; Turner BJ; Yerbury JJ; Cashman NR
Cell Mol Neurobiol; 2016 Apr; 36(3):377-81. PubMed ID: 26908139
[TBL] [Abstract][Full Text] [Related]
28. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.
Mackenzie IR; Bigio EH; Ince PG; Geser F; Neumann M; Cairns NJ; Kwong LK; Forman MS; Ravits J; Stewart H; Eisen A; McClusky L; Kretzschmar HA; Monoranu CM; Highley JR; Kirby J; Siddique T; Shaw PJ; Lee VM; Trojanowski JQ
Ann Neurol; 2007 May; 61(5):427-34. PubMed ID: 17469116
[TBL] [Abstract][Full Text] [Related]
29. Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis.
Ding H; Schwarz DS; Keene A; Affar el B; Fenton L; Xia X; Shi Y; Zamore PD; Xu Z
Aging Cell; 2003 Aug; 2(4):209-17. PubMed ID: 12934714
[TBL] [Abstract][Full Text] [Related]
30. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS.
Turner BJ; Talbot K
Prog Neurobiol; 2008 May; 85(1):94-134. PubMed ID: 18282652
[TBL] [Abstract][Full Text] [Related]
31. Transcriptomic indices of fast and slow disease progression in two mouse models of amyotrophic lateral sclerosis.
Nardo G; Iennaco R; Fusi N; Heath PR; Marino M; Trolese MC; Ferraiuolo L; Lawrence N; Shaw PJ; Bendotti C
Brain; 2013 Nov; 136(Pt 11):3305-32. PubMed ID: 24065725
[TBL] [Abstract][Full Text] [Related]
32. Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis.
Lederer CW; Torrisi A; Pantelidou M; Santama N; Cavallaro S
BMC Genomics; 2007 Jan; 8():26. PubMed ID: 17244347
[TBL] [Abstract][Full Text] [Related]
33. Structural Properties and Interaction Partners of Familial ALS-Associated SOD1 Mutants.
Huai J; Zhang Z
Front Neurol; 2019; 10():527. PubMed ID: 31164862
[TBL] [Abstract][Full Text] [Related]
34. Mutant SOD1 mediated pathogenesis of Amyotrophic Lateral Sclerosis.
Kaur SJ; McKeown SR; Rashid S
Gene; 2016 Feb; 577(2):109-18. PubMed ID: 26657039
[TBL] [Abstract][Full Text] [Related]
35. Compartment specific mitochondrial dysfunction in Drosophila knock-in model of ALS reversed by altered gene expression of OXPHOS subunits and pro-fission factor Drp1.
Nemtsova Y; Steinert BL; Wharton KA
Mol Cell Neurosci; 2023 Jun; 125():103834. PubMed ID: 36868541
[TBL] [Abstract][Full Text] [Related]
36. Co-deposition of SOD1, TDP-43 and p62 proteinopathies in ALS: evidence for multifaceted pathways underlying neurodegeneration.
Trist BG; Fifita JA; Hogan A; Grima N; Smith B; Troakes C; Vance C; Shaw C; Al-Sarraj S; Blair IP; Double KL
Acta Neuropathol Commun; 2022 Aug; 10(1):122. PubMed ID: 36008843
[TBL] [Abstract][Full Text] [Related]
37. Does wild-type Cu/Zn-superoxide dismutase have pathogenic roles in amyotrophic lateral sclerosis?
Furukawa Y; Tokuda E
Transl Neurodegener; 2020 Aug; 9(1):33. PubMed ID: 32811540
[TBL] [Abstract][Full Text] [Related]
38. Investigating the contribution of VAPB/ALS8 loss of function in amyotrophic lateral sclerosis.
Kabashi E; El Oussini H; Bercier V; Gros-Louis F; Valdmanis PN; McDearmid J; Mejier IA; Dion PA; Dupre N; Hollinger D; Sinniger J; Dirrig-Grosch S; Camu W; Meininger V; Loeffler JP; René F; Drapeau P; Rouleau GA; Dupuis L
Hum Mol Genet; 2013 Jun; 22(12):2350-60. PubMed ID: 23446633
[TBL] [Abstract][Full Text] [Related]
39. An Iranian familial amyotrophic lateral sclerosis pedigree with p.Val48Phe causing mutation in SOD1: a genetic and clinical report.
Alavi A; Khani M; Nafissi S; Shamshiri H; Elahi E
Iran J Basic Med Sci; 2014 Oct; 17(10):735-9. PubMed ID: 25729540
[TBL] [Abstract][Full Text] [Related]
40. Human SOD1 ALS Mutations in a Drosophila Knock-In Model Cause Severe Phenotypes and Reveal Dosage-Sensitive Gain- and Loss-of-Function Components.
Şahin A; Held A; Bredvik K; Major P; Achilli TM; Kerson AG; Wharton K; Stilwell G; Reenan R
Genetics; 2017 Feb; 205(2):707-723. PubMed ID: 27974499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
